ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants

Clinical trial NCT06293742 · COMPLETED

Trial details

NCT number: NCT06293742
Sponsor: Eccogene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2024-02-08
Primary completion: 2024-04-15
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.